Results 221 to 230 of about 1,959,855 (381)

Staging lung cancer: total-body PET/CT or whole-body PET/CT? [PDF]

open access: yesEJNMMI Res
Zhang X   +9 more
europepmc   +1 more source

Basal cell carcinoma with metastasis to bone.Report of two cases [PDF]

open access: bronze, 1967
Dieter Assor
openalex   +1 more source

Report on the 2nd MObility for Vesicle research in Europe (MOVE) symposium—2024

open access: yesFEBS Open Bio, EarlyView.
The 2nd MObility for Vesicle research in Europe (MOVE) Symposium in Belgrade brought over 280 attendees from 28 countries to advance extracellular vesicle (EV) research. Featuring keynotes, presentations, and industry sessions, it covered EV biogenesis, biomarkers, therapies, and manufacturing.
Dorival Mendes Rodrigues‐Junior   +5 more
wiley   +1 more source

Erratum to Bcl-2 expression is a poor predictor for hepatocellular carcinoma prognosis of andropause-age patients

open access: yesCancer Biology & Medicine, 2017
Xiao-Fei Zhang   +16 more
doaj   +1 more source

Granular-cell ameloblastoma with metastasis to the lungs.Report of a case and review of the literature [PDF]

open access: bronze, 1965
Yoshiaki Tsukada   +2 more
openalex   +1 more source

Apalutamide Treatment and Metastasis‐free Survival in Prostate Cancer

open access: yesNew England Journal of Medicine, 2018
Matthew R. Smith   +17 more
semanticscholar   +1 more source

Lactoferrin treatment activates acetylcholinesterase, decreasing acetylcholine levels in non‐small cell lung cancer (NSCLC) cell culture supernatants, inhibiting cell survival

open access: yesFEBS Open Bio, EarlyView.
Representation of the suggested mode of action of lactoferrin (Lf) in nonsmall cell lung cancer (NSCLC) A549 cells. Lf induces activation of caspase‐3 by activating p53 and AChE leading to decreased ACh concentrations. In turn, ACh signaling leads to activation of VEGF and AKT and blocking of caspase‐3.
Stuti Goel   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy